Toth Financial Advisory Corp cut its stake in shares of Clorox Co. (NYSE:CLX) by 2.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,533 shares of the company’s stock after selling 912 shares during the period. Toth Financial Advisory Corp’s holdings in Clorox were worth $4,073,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Checchi Capital Advisers LLC raised its position in Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock valued at $113,000 after buying an additional 8 shares during the last quarter. Feltz Wealth PLAN Inc. bought a new position in Clorox during the second quarter valued at $114,000. Valley National Advisers Inc. raised its position in Clorox by 0.6% in the second quarter. Valley National Advisers Inc. now owns 845 shares of the company’s stock valued at $117,000 after buying an additional 5 shares during the last quarter. Blue Chip Partners Inc. raised its position in Clorox by 7.1% in the second quarter. Blue Chip Partners Inc. now owns 890 shares of the company’s stock valued at $123,000 after buying an additional 59 shares during the last quarter. Finally, Assetmark Inc. raised its position in Clorox by 113.2% in the second quarter. Assetmark Inc. now owns 968 shares of the company’s stock valued at $134,000 after buying an additional 514 shares during the last quarter. 69.32% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Clorox Co. (NYSE:CLX) traded up 0.24% on Tuesday, reaching $117.69. The company’s stock had a trading volume of 1,227,171 shares. The company has a market cap of $15.15 billion, a P/E ratio of 23.69 and a beta of 0.36. Clorox Co. has a 52-week low of $111.24 and a 52-week high of $140.47. The firm’s 50-day moving average price is $117.48 and its 200 day moving average price is $127.41.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, November 2nd. The company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.42 by $0.06. Clorox had a net margin of 11.27% and a return on equity of 250.82%. The company earned $1.44 billion during the quarter, compared to the consensus estimate of $1.24 billion. During the same quarter last year, the firm posted $1.32 EPS. The company’s quarterly revenue was up 3.8% on a year-over-year basis. Equities analysts anticipate that Clorox Co. will post $5.32 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 10th. Stockholders of record on Wednesday, January 25th will be paid a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.72%. The ex-dividend date is Monday, January 23rd. Clorox’s dividend payout ratio is 64.26%.

COPYRIGHT VIOLATION WARNING: This report was originally posted by Daily Political and is owned by of Daily Political. If you are reading this report on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this report can be viewed at http://www.dailypolitical.com/2016/11/29/clorox-co-clx-stake-lowered-by-toth-financial-advisory-corp.html.

Several research firms have weighed in on CLX. Zacks Investment Research raised Clorox from a “sell” rating to a “hold” rating in a research note on Friday, November 18th. B. Riley reissued a “neutral” rating and issued a $111.00 target price on shares of Clorox in a research note on Monday, November 14th. Goldman Sachs Group Inc. reaffirmed a “neutral” rating and set a $130.00 price target on shares of Clorox in a research report on Thursday, August 4th. Citigroup Inc. raised their price target on Clorox from $134.00 to $144.00 and gave the stock a “neutral” rating in a research report on Monday, August 8th. Finally, Atlantic Securities raised Clorox from a “hold” rating to a “buy” rating and set a $144.00 price target on the stock in a research report on Friday, September 16th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company’s stock. Clorox presently has an average rating of “Hold” and an average target price of $127.30.

In other news, EVP Laura Stein sold 38,882 shares of the business’s stock in a transaction dated Friday, September 2nd. The stock was sold at an average price of $131.69, for a total value of $5,120,370.58. Following the transaction, the executive vice president now directly owns 48,501 shares of the company’s stock, valued at approximately $6,387,096.69. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.74% of the stock is owned by insiders.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

5 Day Chart for NYSE:CLX

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).

Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.